Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Clinical Investigational Study of AnkuraTM II AAA, IE and AE Stent Graft System for Endovascular Treatment of Abdominal Aortic Aneurysm

NCT: NCT07754240 · NOT_YET_RECRUITING

NCT IDNCT07754240
StatusNOT_YET_RECRUITING
Start Date2026-09-30
Completion2033-05-30
SponsorLifetech Scientific (Shenzhen) Co., Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this clinical investigational study is to evaluate the safety and efficacy of the Ankura™ II AAA, AE Stent Graft System and the large-size Ankura™ II IE Stent Graft System (i.e., IE stent grafts with distal diameters of 24, 26, and 28 mm) for endovascular treatment of abdominal aortic aneurysm in patients with infrarenal abdominal aortic aneurysm who are suitable for endovascular intervention. The primary safety endpoint is the incidence of major adverse events within 30 days after the procedure. The primary efficacy endpoint is the 12-month treatment success rate.

Frequently Asked Questions

What is A Clinical Investigational Study of AnkuraTM II AAA, IE and AE Stent Graft System for Endovascular Treatment of Abdominal Aortic Aneurysm?

A Clinical Investigational Study of AnkuraTM II AAA, IE and AE Stent Graft System for Endovascular Treatment of Abdominal Aortic Aneurysm is a clinical trial registered under NCT07754240. Current status: NOT_YET_RECRUITING.

What is the status of NCT07754240?

The current status of NCT07754240 (A Clinical Investigational Study of AnkuraTM II AAA, IE and AE Stent Graft System for Endovascular Treatment of Abdominal Aortic Aneurysm) is: NOT_YET_RECRUITING.

When did A Clinical Investigational Study of AnkuraTM II AAA, IE and AE Stent Graft System for Endovascular Treatment of Abdominal Aortic Aneurysm start?

A Clinical Investigational Study of AnkuraTM II AAA, IE and AE Stent Graft System for Endovascular Treatment of Abdominal Aortic Aneurysm started on 2026-09-30.

Related Devices

PMA P020018SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTCook, Inc. PMA P040002SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTEndologix, LLC PMA P070007SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTMedtronic Vascular PMA P070016SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTWilliam Cook Europe Aps PMA P070027SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTMedtronic Vascular

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑